Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Busch

Showing results (51-60 of 844) with videos related to

Pageof 85
Sort By:
Clinical Genetics|October 31, 2001
Genetic determinants of type 2 diabetes mellitusC P Busch, R A Hegele
The New England Journal of Medicine|January 2, 1992
Hepatitis C virus replicationM P Busch, J C Wilber
The Journal of Infectious Diseases|April 24, 2009
Use of blood-donor and transfusion-recipient biospecimen repositories to address emerging blood-safety concerns and advance infectious disease research: the National Heart, Lung, and Blood Institute Biologic Specimen RepositoryMichael P Busch, Simone A Glynn
Journal of Cardiovascular Risk|January 6, 2001
Variation of candidate genes in triglyceride metabolismC P Busch, R A Hegele
Molecular Diagnosis & Therapy|May 4, 2006
New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methodsMary C Kuhns, Michael P Busch
Transfusion|April 16, 2016
Remembering James W. Mosley, MD (1929-2015), and his legacy in transfusion safetyMichael P Busch, Girish N Vyas
Transfusion Medicine (Oxford, England)|September 11, 2002
Nucleic acid amplification technology methods used in blood donor screeningP R Grant, M P Busch
AIDS (London, England)|July 30, 2005
Nucleic acid amplification testing for diagnosis of acute HIV infection: has the time come?Michael P Busch, Frederick M Hecht
Transfusion|November 1, 1992
Idiopathic CD4+ T-lymphocytopenia (ICL) and the safety of blood transfusions: what do we know and what should we do?M P Busch, P V Holland
Transfusion|November 3, 2000
NAT and blood safety: what is the paradigm?M P Busch, R Y Dodd
Pageof 85

Showing results (51-60 of 844) with videos related to

Sort By:
Pageof 85
Clinical Genetics|October 31, 2001
Genetic determinants of type 2 diabetes mellitusC P Busch, R A Hegele
The New England Journal of Medicine|January 2, 1992
Hepatitis C virus replicationM P Busch, J C Wilber
The Journal of Infectious Diseases|April 24, 2009
Use of blood-donor and transfusion-recipient biospecimen repositories to address emerging blood-safety concerns and advance infectious disease research: the National Heart, Lung, and Blood Institute Biologic Specimen RepositoryMichael P Busch, Simone A Glynn
Journal of Cardiovascular Risk|January 6, 2001
Variation of candidate genes in triglyceride metabolismC P Busch, R A Hegele
Molecular Diagnosis & Therapy|May 4, 2006
New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methodsMary C Kuhns, Michael P Busch
Transfusion|April 16, 2016
Remembering James W. Mosley, MD (1929-2015), and his legacy in transfusion safetyMichael P Busch, Girish N Vyas
Transfusion Medicine (Oxford, England)|September 11, 2002
Nucleic acid amplification technology methods used in blood donor screeningP R Grant, M P Busch
AIDS (London, England)|July 30, 2005
Nucleic acid amplification testing for diagnosis of acute HIV infection: has the time come?Michael P Busch, Frederick M Hecht
Transfusion|November 1, 1992
Idiopathic CD4+ T-lymphocytopenia (ICL) and the safety of blood transfusions: what do we know and what should we do?M P Busch, P V Holland
Transfusion|November 3, 2000
NAT and blood safety: what is the paradigm?M P Busch, R Y Dodd
Pageof 85